Insights on the Medication Adherence Systems & Technologies Global Market to 2025 - Players Include Abiogenix, Actualmeds & Adheretech Among Others - ResearchAndMarkets.com
This report is an analytical business tool whose primary purpose is to provide a thorough evaluation of the global market for medication adherence.
Medication adherence systems include hardware-based systems (e.g., smart pill bottles, smart caps, automated pill dispensers, electronic trays, smart medical watches, smart medical alarms, wearable sensors and other packaging systems) and software-based internet applications (e.g., cloud-based databases, health programs, patient web portals, mobile medication management applications, etc.) designed to improve medication adherence associated with various chronic = diseases.
Medication non-adherence remains a common healthcare problem across developed and developing nations. It is one of the major public health concerns because it adversely impacts patient outcomes, increases healthcare utilization and associated costs.
Companies Mentioned
Abiogenix
Actualmeds Corp.
Adheretech Inc.
Adherium Ltd.
Apothesource Llc
Carespeak Communications Inc. (Now Part Of Optimizerx)
Compliance Meds Technologies
Dosecue Llc
Drfirst.Com Inc.
E-Pill Llc
Etectrx
F65
Health Net Inc.
Healthera Ltd.
Healthprize Technologies Llc
Information Mediary Corp.
Mango Health Inc. (Trial Card)
Manrex Ltd.
Medacheck
Medadvisor International Pty Ltd.
Medcenter Systems Llc
Medicpen Ab
Medminder
Medvantx Inc.
Memotext Corp.
Mscripts Llc
Mymeds Inc.
Omada Health Inc.
Omnicell
Optumhealth Inc.
Pharmright Corp.
Philips Healthcare
Pilldrill Inc.
Quio Technologies Llc
Rxadvance Corp.
Rxante
Senticare Inc.
Smrxt Inc.
Vaica
West Pharmaceutical Services Inc.
The study covers the following:
Detailed description of medication adherence systems and technologies including software applications (apps).
Demographics and cost burden of targeted chronic diseases.
Market characterization, unmet need, market size and segmentation.
Market drivers and restraints.
Detailed market projections through 2025.
Competition and market shares.
Key marketed products along with information about their regulatory status.
Strategic landscape (merger and acquisitions).
Regulatory structure.
Pricing and reimbursement.
Observations and conclusions on the future of medication adherence systems and technologies.
Profiles of market participants and associations.
Report Includes:
20 data tables and 16 additional tables
An overview of the global markets and technologies for medication adherence
Analyses of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
Description of disease and economic burden, and cost and morbidity in chronic diseases such as cardiovascular diseases (CVD), musculoskeletal disorders, gastrointestinal/digestive diseases, and cancer
Details about adherence measurement, medication adherence and non-economic factors and methods to improve medication adherence
Market share analysis of the medication adherence markets based on product/services, disease and region
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size, and market forecast of the medication adherence systems markets
Discussion on advantages of software and mobile applications, and effectiveness of smartphone adherence apps on the general population
Information on key marketed and pipeline products challenges to improving medication adherence with technology and future developments of the industry
Insights into regulation and reimbursement scenarios including, U.S. FDA technical considerations, FDA policy for low-risk and general wellness devices and regulatory systems for medication adherence systems and applications
A look at the key industry acquisitions, strategic alliances and market share analysis of the leading suppliers of the industry
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Target Diseases and Disorders
Cardiovascular Diseases (CVD)
Angina Pectoris
Stroke
Hypertension
Musculoskeletal Disorders
Epidemiology and Economic Burden
Mortality
Gastrointestinal/Digestive Diseases
Epidemiology and Economic Burden
Mortality
Common Gastrointestinal Diseases and Disorders
Breast Cancer
Disease Overview
Epidemiology and Economic Burden
Colorectal Cancer
Disease Overview
Epidemiology and Economic Burden
Mortality
Diagnosis and Treatment
Small-Bowel Tumors/Diseases
Disease Overview
Epidemiology and Economic Burden
Diagnosis and Treatment
HIV/AIDS
Disease Overview
Epidemiology and Economic Burden
Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Disease Overview
Epidemiology and Economic Burden
Diabetes
Disease Overview
Disease Symptoms and Risk Factors
Epidemiology and Economic Burden
Types of Diabetes
Obesity
Disease Overview
Measuring Obesity
Types of Obesity and Risk Factors
Economic Burden
Epidemiology
Chapter 4 Medication Nonadherence
Chapter 5 Medication Adherence Systems
Chapter 6 Software Applications
Chapter 7 Market Size and Growth Analysis
Major Developments Influencing the Market
Technological Developments
Social Developments: Social Media and Rise of Smartphone Use
Demographic and Economic Trends: Income Growth in Developing Markets
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints
Market Size and Growth Analysis
Market Size and Growth Analysis by Segment
Market Size and Growth Analysis by Disease Application
Market Size and Growth Analysis by Region
Chapter 8 Competitive Landscape
Introduction
Recent Industry Activity
Chapter 9 Regulatory Structure
Chapter 10 Pricing and Reimbursement: Medical Devices
U.S.
Health Insurance Portability and Accountability Act
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...
ThinkCX Technologies Inc., a pioneer in advanced data analytics for the telecom sector, today announced the US launch of its groundbreaking product, Mobile SwitchInsight, set to redefine market intelligence capabilities for US wireless carriers....
Kore Digital Mining Ltd, a UK based Bitcoin mining company, announces that effective 1st May 2024, an additional 14 PH/s mining capacity will be added to its existing infrastructure.
This additional capacity will be provided by a major Bitcoin...
Orezone Gold Corporation (the "Company" or "Orezone") is pleased to provide drill results from its Bomboré Gold Mine located in central Burkina Faso. The results are part of Orezone's ongoing infill and advanced grade control program which was...
Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto,...
Global entertainment platform delivers Revenue of $79 million and strong profitability, including Net Income of $3.3 million up 33% YoY and Total Adjusted EBITDA Margin(1) of 40.5% up more than 300 basis points YoY.IMAX system installations climb...